Back

Anti-inflammatory effects of 12-HHT via epithelial barrier enhancement in colon organoids of normoganglionosis in Hirschsprungs disease

Suda, K.; Abe, K.; Nishimura, Y.; Tanaka, M.; Nagasako, Y.; Rao, X.; Zhang, J.; Zeng, S.; Fujiwara, K.; Yamada, S.; Ishii, J.; Yoshida, S.; Shibuya, S.; Miyano, G.

2026-02-19 gastroenterology
10.64898/2026.02.18.26346528 medRxiv
Show abstract

PurposeHirschsprung-associated enterocolitis remains a major postoperative complication of Hirschsprungs disease (HD), and impaired epithelial barrier integrity has been proposed as a contributing factor. In this study, we investigated whether 12-hydroxyheptadecatrienoic acid (12-HHT), an endogenous leukotriene B4 receptor 2 (BLT-2) agonist, enhances the epithelial barrier and exerts anti-inflammatory effects in patient-derived colonic organoids. MethodsNormoganglionic specimens from rectal/rectosigmoid HD at pull-through (HD-N; n = 8) and transverse colon specimens from anorectal malformation (ARM) at colostomy closure (n = 10) were used to generate colonic organoids. Epithelia were isolated using ethylenediaminetetraacetic acid and subsequently embedded in Matrigel. Baseline expression of TJP1, TJP2, F11R (encoding junctional adhesion molecule-A), JAM2, CLDN1, CLDN3, CLDN4) and LTB4R2 (encoding BLT-2) was assessed by qPCR and immunoblotting. Organoids were then treated with 12-HHT (0.4, 2, or 10 M) for 7 days, followed by qPCR. Additional experiments assessed cytokine expression (IL1B, IL6) and TJPs after 24 h with tumor necrosis factor- (TNF-, 100 ng/mL) plus phosphate buffered saline or 12-HHT. Barrier function was evaluated using FITC-dextran influx assays. ResultsHD-N and ARM organoids exhibited similar growth efficiencies. Baseline expression for F11R, JAM2, CLDN1, CLDN3, CLDN4, and LTB4R2 was significantly lower in HD-N than in ARM. TJPs were upregulated by 12-HHT at 2 and 10 M in both groups, with stronger effects in ARM. In HD-N organoids, 10 M 12-HHT suppressed TNF--induced IL1B and IL6 elevation mitigated tight junction proteins (TJPs) downregulation more effectively than 2 M. 12-HHT attenuated TNF--induced FITC-dextran influx in HD-N organoids. Conclusion12-HHT may exert anti-inflammatory effects by integrating TJPs of HD-N.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Inflammatory Bowel Diseases
15 papers in training set
Top 0.1%
14.9%
2
Gastroenterology
40 papers in training set
Top 0.2%
10.4%
3
PLOS ONE
4510 papers in training set
Top 21%
8.7%
4
American Journal of Gastroenterology
15 papers in training set
Top 0.1%
8.7%
5
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
7.1%
6
Scientific Reports
3102 papers in training set
Top 15%
6.6%
50% of probability mass above
7
American Journal of Physiology-Gastrointestinal and Liver Physiology
11 papers in training set
Top 0.1%
5.0%
8
Journal of Clinical Medicine
91 papers in training set
Top 1.0%
4.1%
9
Frontiers in Medicine
113 papers in training set
Top 1%
3.7%
10
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
2.8%
11
Frontiers in Pharmacology
100 papers in training set
Top 1%
2.2%
12
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.3%
1.7%
13
Biomolecules
95 papers in training set
Top 0.7%
1.4%
14
JCI Insight
241 papers in training set
Top 5%
1.3%
15
Gut
36 papers in training set
Top 0.6%
1.1%
16
Clinical and Translational Science
21 papers in training set
Top 0.7%
1.1%
17
Microbial Cell Factories
22 papers in training set
Top 0.3%
1.0%
18
Biomedicines
66 papers in training set
Top 2%
0.8%
19
mBio
750 papers in training set
Top 10%
0.8%
20
Journal of Cystic Fibrosis
15 papers in training set
Top 0.2%
0.8%
21
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.8%
22
Cureus
67 papers in training set
Top 5%
0.7%
23
BMC Medicine
163 papers in training set
Top 7%
0.7%
24
Frontiers in Physiology
93 papers in training set
Top 7%
0.7%
25
Genes
126 papers in training set
Top 4%
0.7%
26
Neurogastroenterology & Motility
13 papers in training set
Top 0.1%
0.7%
27
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 1.0%
0.5%